After weathering the Vioxx storm for the past three years, Merck again finds itself in choppy and unchartered waters. Still reeling from the Vytorin flap that erupted two months ago, there are new allegations that its blockbuster allergy and asthma medicine, Singulair, may be linked to suicide. The US Food and Drug administration (FDA) was quick (this time) to announce that it is launching an investigation into reports that suggest that Singulair may cause patients taking the medication to commit suicide. Merck received approval for Singulair in 1998 and it had sales of $4.3 billion in 2007.
There are several reasons why FDA quickly alerted the American public to its investigation into Singulair.
Discuss Add this link to... Bury
There are several reasons why FDA quickly alerted the American public to its investigation into Singulair.
Discuss Add this link to... Bury
Comments